A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).

NCT02980731 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
210
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AbbVie